Incyte is a pharmaceutical company focusing on drug discovery, development, and building a proprietary product pipeline of novel small molecule drugs. Established in 2002, the company has a primary focus on oncology and inflammation, and its pipeline includes compounds in various stages of development. Partnering with industry giants like Novartis, Eli Lilly, and Pfizer, the company aims to promote the clinical development and global commercialization of its compounds.
Founded in Delaware, Incyte has grown into a key player in the pharmaceutical industry with 1,600 employees and an annual revenue of $3.4 billion. The company, led by CEO Herv� Hoppenot, boasts a diverse workforce that is 41% female and 46.8% ethnic minorities. The average employee at Incyte earns a competitive salary of $103,592 per year, rivaling those offered by competitors such as Bristol-Myers Squibb, Eli Lilly and Company, and Gilead Sciences.